ClinicalTrials.gov
ClinicalTrials.gov Menu

Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00452205
Recruitment Status : Unknown
Verified August 2009 by Komagome Hospital.
Recruitment status was:  Recruiting
First Posted : March 27, 2007
Last Update Posted : August 4, 2009
Sponsor:
Information provided by:
Komagome Hospital

Brief Summary:
The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointestinal tract.

Condition or disease
Gastrointestinal Neoplasms

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract
Study Start Date : April 2007
Estimated Study Completion Date : March 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Biospecimen Retention:   Samples With DNA
tissue


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients received bone marrow transplantation in Tokyo Metropolitan Komagome Hospital
Criteria

Inclusion Criteria:

  • After allogeneic bone marrow transplantation

Exclusion Criteria:

  • Contraindication for gastrointestinal endoscopy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00452205


Contacts
Contact: Naoto Egawa, MD +81-3-3823-2101 ext 6158 naoto@cick.jp
Contact: Hisashi Sakamaki, MD +81-3-3823-2101 ext 6153 sakamaki@cick.jp

Locations
Japan
Cancer and Infection Disease Center, Komagome Recruiting
Tokyo, Bunkyo-ku, Japan, 113-8677
Contact: Naoto Egawa, MD    +81-3-3823-2101 ext 6158    naoto@cick.jp   
Contact: Hisashi Sakamaki, MD    +81-3-3823-2101 ext 6153    sakamaki@cick.jp   
Principal Investigator: Naoto Egawa, MD         
Sponsors and Collaborators
Komagome Hospital
Investigators
Study Director: Naoto Egawa, MD

Publications:
Responsible Party: Naoto Egawa, Tokyo Metropolitan Komagome Hospital
ClinicalTrials.gov Identifier: NCT00452205     History of Changes
Other Study ID Numbers: CICK-07521
First Posted: March 27, 2007    Key Record Dates
Last Update Posted: August 4, 2009
Last Verified: August 2009

Keywords provided by Komagome Hospital:
bone marrow-derived stem cell
bone marrow transplantation
graft versus host disease
gastrointestinal cancer
after receiving bone marrow transplantation

Additional relevant MeSH terms:
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases